207 related articles for article (PubMed ID: 1348403)
1. Comparative effects of digoxin and xamoterol on arrhythmias in patients with mild to moderate heart failure.
Klein W; Eber B; Rotman B
Angiology; 1992 Apr; 43(4):281-6. PubMed ID: 1348403
[TBL] [Abstract][Full Text] [Related]
2. Digoxin and xamoterol in patients with moderate chronic heart failure. A double-blind, randomized, controlled study.
Sorensen EV; Sterndorff B; Andersen MF; Faergeman O
Cardiovasc Drugs Ther; 1989 Apr; 3(2):203-9. PubMed ID: 2577283
[TBL] [Abstract][Full Text] [Related]
3. The effects of the partial beta 1-agonist xamoterol on heart rate and ventricular arrhythmias in patients with mild to moderate heart failure.
Virk SJ; Anfilogoff NH; Lawson N; Qiang F; Murray RG; Littler WA; Davies MK
Eur Heart J; 1990 Oct; 11(10):876-84. PubMed ID: 1979946
[TBL] [Abstract][Full Text] [Related]
4. Acute and chronic hemodynamic effects of xamoterol in mild to moderate congestive heart failure.
Virk SJ; Qiang FX; Anfilogoff NH; Murray RG; Littler WA; Davies MK
Am J Cardiol; 1991 May; 67(12):48C-52C; discussion 52C-54C. PubMed ID: 1673587
[TBL] [Abstract][Full Text] [Related]
5. Double-blind placebo-controlled comparison of digoxin and xamoterol in chronic heart failure. The German and Austrian Xamoterol Study Group.
Lancet; 1988 Mar; 1(8584):489-93. PubMed ID: 2893916
[TBL] [Abstract][Full Text] [Related]
6. Comparative effects of xamoterol and digoxin in patients with mild to moderate heart failure. The Italian Xamoterol Multicenter Research Group.
Eur Heart J; 1990 Apr; 11 Suppl A():50-1. PubMed ID: 1971591
[TBL] [Abstract][Full Text] [Related]
7. Placebo controlled trial of xamoterol versus digoxin in chronic atrial fibrillation.
Ang EL; Chan WL; Cleland JG; Moore D; Krikler SJ; Alexander ND; Oakley CM
Br Heart J; 1990 Oct; 64(4):256-60. PubMed ID: 1977430
[TBL] [Abstract][Full Text] [Related]
8. Xamoterol in severe heart failure. The Xamoterol in Severe Heart Failure Study Group.
Lancet; 1990 Jul; 336(8706):1-6. PubMed ID: 1694945
[TBL] [Abstract][Full Text] [Related]
9. Xamoterol versus digoxin in heart failure.
Lancet; 1988 Apr; 1(8590):877. PubMed ID: 2895376
[No Abstract] [Full Text] [Related]
10. Effects of xamoterol in acute myocardial infarction: blood pressure, heart rate, arrhythmias and early clinical course.
McMurray J; Lang CC; MacLean D; Struthers AD; McDevitt DG
Int J Cardiol; 1991 Jun; 31(3):295-303. PubMed ID: 1679047
[TBL] [Abstract][Full Text] [Related]
11. Exercise capacity, arrhythmias, humoral and chemical parameters during long-term therapy with xamoterol.
Erlemeier HH; Kupper W; Bleifeld W
Int J Cardiol; 1990 Aug; 28(2):197-208. PubMed ID: 1697569
[TBL] [Abstract][Full Text] [Related]
12. [Role of adrenergic beta receptor partial agonists in left ventricular failure of ischemic origin. Value of xamoterol (ICI 118,587, Corwin)].
Rousseau MF; Cheron P; Nannan M; Vincent MF; Lavenne F; Pouleur H
Ann Med Interne (Paris); 1985; 136(3):247-50. PubMed ID: 2862823
[TBL] [Abstract][Full Text] [Related]
13. Review of clinical experience with xamoterol. Effects on exercise capacity and symptoms in heart failure.
Marlow HF
Circulation; 1990 Feb; 81(2 Suppl):III93-8. PubMed ID: 1967561
[TBL] [Abstract][Full Text] [Related]
14. Clinical efficacy of xamoterol, a beta 1-adrenoceptor partial agonist, in mild to moderate heart failure. U.K. Xamoterol Study Group.
Waller DG; Webster J; Sykes CA; Bhalla KK; Wray R
Eur Heart J; 1989 Nov; 10(11):1003-10. PubMed ID: 2574108
[TBL] [Abstract][Full Text] [Related]
15. Xamoterol, a beta 1-adrenoceptor partial agonist: review of the clinical efficacy in heart failure.
Marlow HF
Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):23S-30S. PubMed ID: 2572251
[TBL] [Abstract][Full Text] [Related]
16. [How to select newly-developed oral inotropic agents: an evaluation based on their effects on heart rate and arrhythmias].
Fukuda K; Handa S; Ogawa S; Nakamura Y; Kawamura Y
J Cardiol; 1990; 20(3):755-65. PubMed ID: 2151866
[TBL] [Abstract][Full Text] [Related]
17. Long-term efficacy of xamoterol (a beta 1-adrenoceptor partial agonist) in patients with mild to moderate heart failure.
Sørensen EV; Faergeman O; Day MA; Snow HM
Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):86S-88S. PubMed ID: 2572265
[TBL] [Abstract][Full Text] [Related]
18. Lack of tolerance development after long-term administration of the partial beta-adrenoceptor agonist xamoterol.
Erlemeier HH; Kupper W; Bleifeld W
Cardiology; 1990; 77(1):30-9. PubMed ID: 1972349
[TBL] [Abstract][Full Text] [Related]
19. Clinical experience of therapy with xamoterol in patients with severe systolic and diastolic dysfunction.
Pouleur H; Hanet C; Rousseau MF
Eur Heart J; 1990 Apr; 11 Suppl A():33-8. PubMed ID: 1971587
[TBL] [Abstract][Full Text] [Related]
20. Effects of xamoterol on resting and exercise haemodynamics in patients with chronic heart failure.
Virk SJ; Davies MK
Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):15S-22S. PubMed ID: 2572250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]